APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Acting Contraceptive Pills

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long-Acting Contraceptive Pills Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchLong-Acting Contraceptive Pills Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Acting Contraceptive Pills Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Long-Acting Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Acting Contraceptive Pills Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Acting Contraceptive Pills Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Long-Acting Contraceptive Pills market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Long-Acting Contraceptive Pills include Bayer, Cipla, Merck, Sun Pharma, Teva Pharmaceuticals, Pfizer, Mylan, Shanghai Pharmaceuticals and Zhejiang Xianju Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Long-Acting Contraceptive Pills, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long-Acting Contraceptive Pills, also provides the sales of main regions and countries. Of the upcoming market potential for Long-Acting Contraceptive Pills, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-Acting Contraceptive Pills sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-Acting Contraceptive Pills market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Long-Acting Contraceptive Pills sales, projected growth trends, production technology, application and end-user industry.

Long-Acting Contraceptive Pills Segment by Company

Bayer

Cipla

Merck

Sun Pharma

Teva Pharmaceuticals

Pfizer

Mylan

Shanghai Pharmaceuticals

Zhejiang Xianju Pharmaceutical

Long-Acting Contraceptive Pills Segment by Type

Injectables

Subdermal Implants

Intrauterine Devices

Other

Long-Acting Contraceptive Pills Segment by Application

Hospital

Clinic

Long-Acting Contraceptive Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Contraceptive Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Long-Acting Contraceptive Pills in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-Acting Contraceptive Pills sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-Acting Contraceptive Pills Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injectables Major Manufacturers Table 3. Subdermal Implants Major Manufacturers Table 4. Intrauterine Devices Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Long-Acting Contraceptive Pills Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Long-Acting Contraceptive Pills Industry Trends Table 10. Long-Acting Contraceptive Pills Industry Drivers Table 11. Long-Acting Contraceptive Pills Industry Opportunities and Challenges Table 12. Long-Acting Contraceptive Pills Industry Restraints Table 13. Global Long-Acting Contraceptive Pills Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Long-Acting Contraceptive Pills Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Long-Acting Contraceptive Pills Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2026) Table 17. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027-2032) Table 18. Global Long-Acting Contraceptive Pills Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units) Table 20. Global Long-Acting Contraceptive Pills Sales by Region (2027-2032) & (K Units) Table 21. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2026) Table 22. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2027-2032) Table 23. Global Long-Acting Contraceptive Pills Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Long-Acting Contraceptive Pills Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021-2026) Table 27. Global Long-Acting Contraceptive Pills Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Long-Acting Contraceptive Pills Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Long-Acting Contraceptive Pills Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Long-Acting Contraceptive Pills Manufacturers, Product Type & Application Table 31. Global Long-Acting Contraceptive Pills Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Long-Acting Contraceptive Pills by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Long-Acting Contraceptive Pills Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026) Table 38. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027-2032) Table 39. Global Long-Acting Contraceptive Pills Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 41. Global Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 42. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026) Table 43. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027-2032) Table 44. Global Long-Acting Contraceptive Pills Price by Type (2021-2026) & (US$/Unit) Table 45. Global Long-Acting Contraceptive Pills Price by Type (2027-2032) & (US$/Unit) Table 46. Global Long-Acting Contraceptive Pills Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2026) Table 50. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027-2032) Table 51. Global Long-Acting Contraceptive Pills Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 53. Global Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 54. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026) Table 55. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027-2032) Table 56. Global Long-Acting Contraceptive Pills Price by Application (2021-2026) & (US$/Unit) Table 57. Global Long-Acting Contraceptive Pills Price by Application (2027-2032) & (US$/Unit) Table 58. Bayer Company Information Table 59. Bayer Business Overview Table 60. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bayer Long-Acting Contraceptive Pills Product Portfolio Table 62. Bayer Recent Development Table 63. Cipla Company Information Table 64. Cipla Business Overview Table 65. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Cipla Long-Acting Contraceptive Pills Product Portfolio Table 67. Cipla Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck Long-Acting Contraceptive Pills Product Portfolio Table 72. Merck Recent Development Table 73. Sun Pharma Company Information Table 74. Sun Pharma Business Overview Table 75. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sun Pharma Long-Acting Contraceptive Pills Product Portfolio Table 77. Sun Pharma Recent Development Table 78. Teva Pharmaceuticals Company Information Table 79. Teva Pharmaceuticals Business Overview Table 80. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 82. Teva Pharmaceuticals Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Long-Acting Contraceptive Pills Product Portfolio Table 87. Pfizer Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Long-Acting Contraceptive Pills Product Portfolio Table 92. Mylan Recent Development Table 93. Shanghai Pharmaceuticals Company Information Table 94. Shanghai Pharmaceuticals Business Overview Table 95. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 97. Shanghai Pharmaceuticals Recent Development Table 98. Zhejiang Xianju Pharmaceutical Company Information Table 99. Zhejiang Xianju Pharmaceutical Business Overview Table 100. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio Table 102. Zhejiang Xianju Pharmaceutical Recent Development Table 103. North America Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 106. North America Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 107. North America Long-Acting Contraceptive Pills Sales Price by Type (2021-2026) & (US$/Unit) Table 108. North America Long-Acting Contraceptive Pills Sales Price by Type (2027-2032) & (US$/Unit) Table 109. North America Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 112. North America Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 113. North America Long-Acting Contraceptive Pills Sales Price by Application (2021-2026) & (US$/Unit) Table 114. North America Long-Acting Contraceptive Pills Sales Price by Application (2027-2032) & (US$/Unit) Table 115. North America Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 119. North America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 120. North America Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 121. North America Long-Acting Contraceptive Pills Sales Price by Country (2021-2026) & (US$/Unit) Table 122. North America Long-Acting Contraceptive Pills Sales Price by Country (2027-2032) & (US$/Unit) Table 123. United States Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 124. Canada Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 125. Mexico Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 126. Europe Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 129. Europe Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 130. Europe Long-Acting Contraceptive Pills Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Long-Acting Contraceptive Pills Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 135. Europe Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 136. Europe Long-Acting Contraceptive Pills Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Long-Acting Contraceptive Pills Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 143. Europe Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 144. Europe Long-Acting Contraceptive Pills Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Long-Acting Contraceptive Pills Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 147. France Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 148. U.K. Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 149. Italy Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 150. Russia Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 151. Spain Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 154. Sweden Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 155. Poland Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 156. China Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 157. China Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 158. China Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 159. China Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 160. China Long-Acting Contraceptive Pills Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Long-Acting Contraceptive Pills Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 163. China Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 164. China Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 165. China Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 166. China Long-Acting Contraceptive Pills Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Long-Acting Contraceptive Pills Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 171. Asia Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 172. Asia Long-Acting Contraceptive Pills Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Long-Acting Contraceptive Pills Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 177. Asia Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 178. Asia Long-Acting Contraceptive Pills Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Long-Acting Contraceptive Pills Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Asia Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 185. Asia Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 186. Asia Long-Acting Contraceptive Pills Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Long-Acting Contraceptive Pills Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 189. South Korea Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 190. India Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 191. Australia Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 197. SAMEA Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 198. SAMEA Long-Acting Contraceptive Pills Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Long-Acting Contraceptive Pills Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 203. SAMEA Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 204. SAMEA Long-Acting Contraceptive Pills Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Long-Acting Contraceptive Pills Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. SAMEA Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 211. SAMEA Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 212. SAMEA Long-Acting Contraceptive Pills Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Long-Acting Contraceptive Pills Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 215. Argentina Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 216. Chile Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 217. Colombia Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 218. Peru Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 220. Israel Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 221. UAE Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 222. Turkey Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 223. Iran Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 224. Egypt Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Long-Acting Contraceptive Pills Distributors List Table 228. Long-Acting Contraceptive Pills Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Long-Acting Contraceptive Pills Image Figure 2. Global Long-Acting Contraceptive Pills Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Acting Contraceptive Pills Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injectables Image Figure 5. Subdermal Implants Image Figure 6. Intrauterine Devices Image Figure 7. Other Image Figure 8. Global Long-Acting Contraceptive Pills Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Long-Acting Contraceptive Pills Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Long-Acting Contraceptive Pills Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Figure 14. Global Long-Acting Contraceptive Pills Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Long-Acting Contraceptive Pills Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2032) Figure 17. Global Long-Acting Contraceptive Pills Sales (2021-2032) & (K Units) Figure 18. Global Long-Acting Contraceptive Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Long-Acting Contraceptive Pills Sales YoY (2021-2032) & (K Units) Figure 21. Europe Long-Acting Contraceptive Pills Sales YoY (2021-2032) & (K Units) Figure 22. China Long-Acting Contraceptive Pills Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Long-Acting Contraceptive Pills Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales YoY (2021-2032) & (K Units) Figure 25. Global Long-Acting Contraceptive Pills Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Long-Acting Contraceptive Pills Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Long-Acting Contraceptive Pills Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Long-Acting Contraceptive Pills Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032) Figure 31. Global Long-Acting Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Long-Acting Contraceptive Pills Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032) Figure 34. Global Long-Acting Contraceptive Pills Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Long-Acting Contraceptive Pills Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032) Figure 37. Global Long-Acting Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Long-Acting Contraceptive Pills Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032) Figure 40. North America Long-Acting Contraceptive Pills Revenue Share by Type (2021-2032) Figure 41. North America Long-Acting Contraceptive Pills Sales Share by Type (2021-2032) Figure 42. North America Long-Acting Contraceptive Pills Revenue Share by Application (2021-2032) Figure 43. North America Long-Acting Contraceptive Pills Sales Share by Application (2021-2032) Figure 44. North America Long-Acting Contraceptive Pills Revenue Share by Country (2021-2032) Figure 45. North America Long-Acting Contraceptive Pills Sales Share by Country (2021-2032) Figure 46. Europe Long-Acting Contraceptive Pills Revenue Share by Type (2021-2032) Figure 47. Europe Long-Acting Contraceptive Pills Sales Share by Type (2021-2032) Figure 48. Europe Long-Acting Contraceptive Pills Revenue Share by Application (2021-2032) Figure 49. Europe Long-Acting Contraceptive Pills Sales Share by Application (2021-2032) Figure 50. Europe Long-Acting Contraceptive Pills Revenue Share by Country (2021-2032) Figure 51. Europe Long-Acting Contraceptive Pills Sales Share by Country (2021-2032) Figure 52. China Long-Acting Contraceptive Pills Revenue Share by Type (2021-2032) Figure 53. China Long-Acting Contraceptive Pills Sales Share by Type (2021-2032) Figure 54. China Long-Acting Contraceptive Pills Revenue Share by Application (2021-2032) Figure 55. China Long-Acting Contraceptive Pills Sales Share by Application (2021-2032) Figure 56. Asia Long-Acting Contraceptive Pills Revenue Share by Type (2021-2032) Figure 57. Asia Long-Acting Contraceptive Pills Sales Share by Type (2021-2032) Figure 58. Asia Long-Acting Contraceptive Pills Revenue Share by Application (2021-2032) Figure 59. Asia Long-Acting Contraceptive Pills Sales Share by Application (2021-2032) Figure 60. Asia Long-Acting Contraceptive Pills Revenue Share by Country (2021-2032) Figure 61. Asia Long-Acting Contraceptive Pills Sales Share by Country (2021-2032) Figure 62. SAMEA Long-Acting Contraceptive Pills Revenue Share by Type (2021-2032) Figure 63. SAMEA Long-Acting Contraceptive Pills Sales Share by Type (2021-2032) Figure 64. SAMEA Long-Acting Contraceptive Pills Revenue Share by Application (2021-2032) Figure 65. SAMEA Long-Acting Contraceptive Pills Sales Share by Application (2021-2032) Figure 66. SAMEA Long-Acting Contraceptive Pills Revenue Share by Country (2021-2032) Figure 67. SAMEA Long-Acting Contraceptive Pills Sales Share by Country (2021-2032) Figure 68. Long-Acting Contraceptive Pills Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Long-Acting Contraceptive Pills Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Bayer
  • Cipla
  • Merck
  • Sun Pharma
  • Teva Pharmaceuticals
  • Pfizer
  • Mylan
  • Shanghai Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long-Acting Contraceptive Pills Market by Type
  3. 1.2.1 Global Long-Acting Contraceptive Pills Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injectables
  5. 1.2.3 Subdermal Implants
  6. 1.2.4 Intrauterine Devices
  7. 1.2.5 Other
  8. 1.3 Long-Acting Contraceptive Pills Market by Application
  9. 1.3.1 Global Long-Acting Contraceptive Pills Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Long-Acting Contraceptive Pills Market Dynamics
  1. 2.1 Long-Acting Contraceptive Pills Industry Trends
  2. 2.2 Long-Acting Contraceptive Pills Industry Drivers
  3. 2.3 Long-Acting Contraceptive Pills Industry Opportunities and Challenges
  4. 2.4 Long-Acting Contraceptive Pills Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Long-Acting Contraceptive Pills Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Long-Acting Contraceptive Pills Revenue by Region
  3. 3.2.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long-Acting Contraceptive Pills Revenue by Region (2021-2026)
  5. 3.2.3 Global Long-Acting Contraceptive Pills Revenue by Region (2027-2032)
  6. 3.2.4 Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Long-Acting Contraceptive Pills Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Long-Acting Contraceptive Pills Sales by Region
  9. 3.4.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Long-Acting Contraceptive Pills Sales by Region (2021-2026)
  11. 3.4.3 Global Long-Acting Contraceptive Pills Sales by Region (2027-2032)
  12. 3.4.4 Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Long-Acting Contraceptive Pills Revenue by Manufacturers
  2. 4.1.1 Global Long-Acting Contraceptive Pills Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Long-Acting Contraceptive Pills Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long-Acting Contraceptive Pills Sales by Manufacturers
  6. 4.2.1 Global Long-Acting Contraceptive Pills Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Long-Acting Contraceptive Pills Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Long-Acting Contraceptive Pills Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Long-Acting Contraceptive Pills Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Long-Acting Contraceptive Pills Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Long-Acting Contraceptive Pills Manufacturers, Product Type & Application
  13. 4.7 Global Long-Acting Contraceptive Pills Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Long-Acting Contraceptive Pills Market CR5 and HHI
  16. 4.8.2 2025 Long-Acting Contraceptive Pills Tier 1, Tier 2, and Tier 3
5 Long-Acting Contraceptive Pills Market by Type
  1. 5.1 Global Long-Acting Contraceptive Pills Revenue by Type
  2. 5.1.1 Global Long-Acting Contraceptive Pills Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Long-Acting Contraceptive Pills Sales by Type
  6. 5.2.1 Global Long-Acting Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Long-Acting Contraceptive Pills Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032)
  9. 5.3 Global Long-Acting Contraceptive Pills Price by Type
6 Long-Acting Contraceptive Pills Market by Application
  1. 6.1 Global Long-Acting Contraceptive Pills Revenue by Application
  2. 6.1.1 Global Long-Acting Contraceptive Pills Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Long-Acting Contraceptive Pills Sales by Application
  6. 6.2.1 Global Long-Acting Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Long-Acting Contraceptive Pills Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032)
  9. 6.3 Global Long-Acting Contraceptive Pills Price by Application
7 Company Profiles
  1. 7.1 Bayer
  2. 7.1.1 Bayer Company Information
  3. 7.1.2 Bayer Business Overview
  4. 7.1.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
  6. 7.1.5 Bayer Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
  12. 7.2.5 Cipla Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Long-Acting Contraceptive Pills Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Sun Pharma
  20. 7.4.1 Sun Pharma Company Information
  21. 7.4.2 Sun Pharma Business Overview
  22. 7.4.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
  24. 7.4.5 Sun Pharma Recent Developments
  25. 7.5 Teva Pharmaceuticals
  26. 7.5.1 Teva Pharmaceuticals Company Information
  27. 7.5.2 Teva Pharmaceuticals Business Overview
  28. 7.5.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  30. 7.5.5 Teva Pharmaceuticals Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Shanghai Pharmaceuticals
  44. 7.8.1 Shanghai Pharmaceuticals Company Information
  45. 7.8.2 Shanghai Pharmaceuticals Business Overview
  46. 7.8.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  48. 7.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 7.9 Zhejiang Xianju Pharmaceutical
  50. 7.9.1 Zhejiang Xianju Pharmaceutical Company Information
  51. 7.9.2 Zhejiang Xianju Pharmaceutical Business Overview
  52. 7.9.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
  54. 7.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Long-Acting Contraceptive Pills Market Size by Type
  2. 8.1.1 North America Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  3. 8.1.2 North America Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  4. 8.1.3 North America Long-Acting Contraceptive Pills Price by Type (2021-2032)
  5. 8.2 North America Long-Acting Contraceptive Pills Market Size by Application
  6. 8.2.1 North America Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  7. 8.2.2 North America Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  8. 8.2.3 North America Long-Acting Contraceptive Pills Price by Application (2021-2032)
  9. 8.3 North America Long-Acting Contraceptive Pills Market Size by Country
  10. 8.3.1 North America Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Long-Acting Contraceptive Pills Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Long-Acting Contraceptive Pills Market Size by Type
  2. 9.1.1 Europe Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  3. 9.1.2 Europe Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  4. 9.1.3 Europe Long-Acting Contraceptive Pills Price by Type (2021-2032)
  5. 9.2 Europe Long-Acting Contraceptive Pills Market Size by Application
  6. 9.2.1 Europe Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  7. 9.2.2 Europe Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  8. 9.2.3 Europe Long-Acting Contraceptive Pills Price by Application (2021-2032)
  9. 9.3 Europe Long-Acting Contraceptive Pills Market Size by Country
  10. 9.3.1 Europe Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Long-Acting Contraceptive Pills Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Long-Acting Contraceptive Pills Market Size by Type
  2. 10.1.1 China Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  3. 10.1.2 China Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  4. 10.1.3 China Long-Acting Contraceptive Pills Price by Type (2021-2032)
  5. 10.2 China Long-Acting Contraceptive Pills Market Size by Application
  6. 10.2.1 China Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  7. 10.2.2 China Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  8. 10.2.3 China Long-Acting Contraceptive Pills Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long-Acting Contraceptive Pills Market Size by Type
  2. 11.1.1 Asia Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  3. 11.1.2 Asia Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  4. 11.1.3 Asia Long-Acting Contraceptive Pills Price by Type (2021-2032)
  5. 11.2 Asia Long-Acting Contraceptive Pills Market Size by Application
  6. 11.2.1 Asia Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  7. 11.2.2 Asia Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  8. 11.2.3 Asia Long-Acting Contraceptive Pills Price by Application (2021-2032)
  9. 11.3 Asia Long-Acting Contraceptive Pills Market Size by Country
  10. 11.3.1 Asia Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Long-Acting Contraceptive Pills Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long-Acting Contraceptive Pills Market Size by Type
  2. 12.1.1 SAMEA Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Long-Acting Contraceptive Pills Price by Type (2021-2032)
  5. 12.2 SAMEA Long-Acting Contraceptive Pills Market Size by Application
  6. 12.2.1 SAMEA Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Long-Acting Contraceptive Pills Price by Application (2021-2032)
  9. 12.3 SAMEA Long-Acting Contraceptive Pills Market Size by Country
  10. 12.3.1 SAMEA Long-Acting Contraceptive Pills Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Long-Acting Contraceptive Pills Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Long-Acting Contraceptive Pills Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Long-Acting Contraceptive Pills Value Chain Analysis
  2. 13.1.1 Long-Acting Contraceptive Pills Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Long-Acting Contraceptive Pills Production Mode & Process
  6. 13.2 Long-Acting Contraceptive Pills Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Long-Acting Contraceptive Pills Distributors
  9. 13.2.3 Long-Acting Contraceptive Pills Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst